Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma
Functional Outcome After Transoral Robotic Surgery (TORS) vs Oncological Treatment for Oropharyngeal Squamous Cell Carcinoma
Sponsor: Rigshospitalet, Denmark
A observational or N/A phase clinical study on Human Papilloma Virus and Oropharynx Cancer, this trial is ongoing. The trial is conducted by Rigshospitalet, Denmark and has accumulated 15 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
15 versions recorded-
Apr 2025 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Apr 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Apr 2023 — Jul 2024 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Feb 2023 — Apr 2023 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
▶ Show 10 earlier versions
-
Dec 2021 — Feb 2023 [monthly]
Active Not Recruiting
-
Feb 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jan 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Apr 2019 — Jan 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rigshospitalet, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .